ACTINIUM PHARMACEUTICALS, INC. Finance Lease, Right-of-Use Asset, Amortization
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Finance Lease, Right-of-Use Asset, Amortization of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $2.00K, a 0.00% change year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $2.00K, a 0.00% change year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $3.00K, a 50.00% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $2.00K, a 33.33% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $10.00K, a 0.00% change from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $10.00K, a 233.33% increase from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $3.00K, a 94.55% decline from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $55.00K, a 32.10% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-07 | $5.00K 10-Q · filed 2026-08-07 | $7.00K derived: sum of 3 quarters · filed 2026-08-07 | $9.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-08 | $5.00K derived: sum of 2 quarters · filed 2026-05-08 | $7.00K derived: sum of 3 quarters · filed 2026-05-08 | $9.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.00K derived: sum of 2 quarters · filed 2026-03-30 | $7.00K derived: sum of 3 quarters · filed 2026-08-07 | $10.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-14 | $4.00K derived: sum of 2 quarters · filed 2026-08-07 | $7.00K 10-Q · filed 2025-11-14 | $8.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-07 | $5.00K 10-Q · filed 2026-08-07 | $6.00K derived: sum of 3 quarters · filed 2026-08-07 | $9.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-08 | $4.00K derived: sum of 2 quarters · filed 2026-05-08 | $7.00K derived: sum of 3 quarters · filed 2026-05-08 | $10.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $5.00K derived: sum of 2 quarters · filed 2026-03-30 | $8.00K derived: sum of 3 quarters · filed 2026-03-30 | $10.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $3.00K 10-Q · filed 2025-11-14 | $6.00K derived: sum of 2 quarters · filed 2025-11-14 | $8.00K 10-Q · filed 2025-11-14 | $8.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $3.00K 10-Q · filed 2025-08-08 | $5.00K 10-Q · filed 2025-08-08 | $5.00K derived: sum of 3 quarters · filed 2025-08-08 | $6.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-09 | $2.00K derived: sum of 2 quarters · filed 2025-05-09 | $3.00K derived: sum of 3 quarters · filed 2025-05-09 | $4.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.00K derived: sum of 2 quarters · filed 2025-03-31 | $2.00K derived: sum of 3 quarters · filed 2025-03-31 | $3.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-14 | $2.00K derived: sum of 2 quarters · filed 2024-11-14 | $3.00K 10-Q · filed 2024-11-14 | $4.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.00K 10-Q · filed 2024-08-05 | $2.00K 10-Q · filed 2024-08-05 | $3.00K derived: sum of 3 quarters · filed 2024-08-05 | $17.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-04-26 | $2.00K derived: sum of 2 quarters · filed 2024-04-26 | $16.00K derived: sum of 3 quarters · filed 2024-04-26 | $36.00K derived: sum of 4 quarters · filed 2024-04-26 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $15.00K derived: sum of 2 quarters · filed 2024-03-29 | $35.00K derived: sum of 3 quarters · filed 2024-03-29 | $55.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $14.00K 10-Q · filed 2023-11-02 | $34.00K derived: sum of 2 quarters · filed 2023-11-02 | $54.00K 10-Q · filed 2023-11-02 | $74.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $20.00K 10-Q · filed 2023-08-14 | $41.00K 10-Q · filed 2023-08-14 | $60.00K derived: sum of 3 quarters · filed 2023-08-14 | $80.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $20.00K 10-Q · filed 2023-05-15 | $40.00K derived: sum of 2 quarters · filed 2023-05-15 | $60.00K derived: sum of 3 quarters · filed 2023-05-15 | $81.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $40.00K derived: sum of 2 quarters · filed 2023-03-31 | $61.00K derived: sum of 3 quarters · filed 2023-03-31 | $81.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $20.00K 10-Q · filed 2022-11-14 | $41.00K derived: sum of 2 quarters · filed 2022-11-14 | $61.00K 10-Q · filed 2022-11-14 | $81.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $21.00K 10-Q · filed 2022-08-12 | $41.00K 10-Q · filed 2022-08-12 | $61.00K derived: sum of 3 quarters · filed 2022-08-12 | $81.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $20.00K 10-Q · filed 2022-05-13 | $40.00K derived: sum of 2 quarters · filed 2022-05-13 | $60.00K derived: sum of 3 quarters · filed 2022-05-13 | $81.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $40.00K derived: sum of 2 quarters · filed 2022-03-25 | $61.00K derived: sum of 3 quarters · filed 2022-03-25 | $81.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $20.00K 10-Q · filed 2021-11-12 | $41.00K derived: sum of 2 quarters · filed 2021-11-12 | $61.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $21.00K 10-Q · filed 2021-07-30 | $41.00K 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $20.00K 10-Q · filed 2021-05-14 | |||
| 2019-09-30 | $20.00K 10-Q · filed 2020-10-23 | $61.00K 10-Q · filed 2020-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |